查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1804312

切除技术的全球市场:各类型，各用途，各终端用户，各地区 - 市场规模，产业动态，机会分析，预测(2025年～2034年)

Global Ablation Technology Market: By Type, Application, End Users, Region-Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2034
出版日期: | 出版商: Astute Analytica | 英文 233 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

受心血管疾病 (CVD)、实体肿瘤和慢性疼痛盛行率上升的推动，全球消融技术市场持续快速扩张。 2024 年市场规模估计为 68.2 亿美元，预计到 2034 年将达到 167.4 亿美元，预测期内复合年增长率为 9.82%。技术进步，尤其是脉衝场、低温和微波消融系统，正在推动消融技术的应用不断提升，尤其是在微创手术领域。美国、日本、印度和中国等国家的各个治疗领域消融手术数量正在快速成长。例如，预计到2024年，光是美国就将进行超过48万例心臟消融手术，而全球肿瘤消融手术将超过85万例，其中肝癌消融手术将占三分之一以上。

FDA批准的脉衝场消融 (PFA) 系统、人工智慧映射平台以及一次性探头等创新技术正在改变临床实践。此外，门诊手术中心因其成本效益和效率而越来越受到青睐，目前美国超过55%的消融手术在传统医院外进行。与此同时，由于医疗基础设施的改善、政府举措的出台以及电生理学和肿瘤学专家培训的加强，亚太国家正在经历快速扩张。

值得关注的市场发展

一系列进步正在推动消融技术的发展。脉衝场消融术可降低食道损伤风险并缩短手术时间，正迅速获得广泛认可，目前已占美国心臟消融手术的25%。美敦力的Affera平台和强生与Verily合作的纤维化映射工具等人工智慧引导系统正在提高手术准确性并降低重复消融率。目前，超过90%的肝臟肿瘤门诊消融病例可当天出院，从而提高了医疗系统的效率。同时，在印度等国家，由于术后併发症显着减少，摄护腺冷冻消融术的年增率为22%。

各公司正在合作开发针对门诊环境优化的混合消融系统和模组化套件。例如，美敦力和通用电气医疗集团已合作将即时MRI引导整合到消融平台中，从而改善肿瘤边缘的可视化。不断演变的报销政策进一步支持了此类活动，例如美国扩大了医疗保险覆盖范围，以及巴西旨在降低设备成本和扩大服务欠缺地区医疗服务可及性的公私合作伙伴关係。

关键成长动力

1. 目标疾病盛行率上升：心房颤动 (AFib) 盛行率不断上升，影响全球超过 2,600 万人，局部癌症的盛行率显着上升，这显着增加了对消融治疗的需求。

2. 微创治疗的偏好：消融可以缩短恢復时间、减少创伤并降低住院费用，支持其广泛应用。

3. 技术创新：便携式、整合 AI 的系统和一次性探头的出现改善了治疗效果和病患安全性，尤其是在门诊环境中。

4.政府支持和报销政策：美国医疗保险和医疗补助计划 (CMS) 报销更新和亚太地区医疗补助补贴等政策正在创造良好的市场环境。

新兴科技趋势

  • 基于人工智慧的导航和地图：超过 70% 的美国心臟实验室采用这些技术，可优化消融精度并缩短手术时间。
  • 门诊和心臟外科手术 (ASC) 优化：专为空间受限的门诊环境设计的紧凑型模组化系统在该市场越来越受欢迎。
  • 跨专业整合：製造商优先考虑相容于心臟和肿瘤应用的设备，以最大限度地提高利用率和投资回报率。
  • 整合远端监控：雅培 TriClip 等产品整合了即时数据采集功能，可实现后续护理并降低再入院率。

本报告探讨并分析了全球消融技术市场，提供了每个细分市场的规模和预测、市场动态和趋势以及公司概况。

目录

第1章 调查架构

  • 调查目的
  • 产品概要
  • 市场区隔

第2章 调查手法

第3章 摘要整理:全球切除技术市场

第4章 全球切除技术市场概要

  • 产业价值链分析
    • 材料/零组件供应商
    • 厂商
    • 软体·成像技术供应商
    • 销售商·流通管道合作伙伴
    • 医疗提供者/终端用户
  • 产业预测
    • 医疗器材进出口
    • 人工智慧整合医疗保健
    • 设备监管概述
    • 医疗保健中的数位设备交互
  • 大环境分析
  • 波特的五力分析
  • 市场动态和趋势
    • 成长促进因素
    • 阻碍因素
    • 机会
    • 主要趋势
  • 市场成长及预测
    • 市场收益的估计与预测(2020年～2034年)
  • 竞争仪表板
    • 市场集中率
    • 企业的市场占有率分析(金额)(2024年)
    • 竞争製图和基准
  • 实用的知识见解(分析师的建议)

第5章 全球切除技术市场分析:各类型

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 光/雷射
    • RF
    • 电力
    • 超音波
    • 微波
    • 冷冻治疗
    • 水热/水力机械性切除技术
    • 其他

第6章 全球切除技术市场分析:各用途

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 心血管疾病治疗
    • 癌症治疗
    • 眼科治疗
    • 疼痛管理
    • 妇产科治疗
    • 泌尿科治疗
    • 整形外科治疗
    • 美容整形手术
    • 其他

第7章 全球切除技术市场分析:各终端用户

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 医院
    • 手术中心
    • 切除中心
    • 门诊病人手术中心(ASC)

第8章 全球切除技术市场分析:各地区

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 北美
    • 欧洲
    • 亚太地区
    • 中东·非洲
    • 南美

第9章 北美的切除技术市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 各类型
    • 各用途
    • 各终端用户
    • 各国

第10章 欧洲的切除技术市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 各类型
    • 各用途
    • 各终端用户
    • 各国

第11章 亚太地区的切除技术市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 各类型
    • 各用途
    • 各终端用户
    • 各国

第12章 中东·非洲的切除技术市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 各类型
    • 各用途
    • 各终端用户
    • 各国

第13章 南美的切除技术市场分析

  • 重要的知识见解
  • 市场规模与预测(2020年～2034年)
    • 各类型
    • 各用途
    • 各终端用户
    • 各国

第14章 企业简介

  • Medtronic plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Abbott Laboratories
  • Terumo Medical Corporation
  • CONMED Corporation
  • AtriCure, Inc.
  • Stryker Corporation
  • Accuray
  • Smith & Nephew
  • AngioDynamics, Inc.
  • Varian Medical Systems
  • Olympus Corporation
  • 其他的着名的企业

第15章 附录

简介目录
Product Code: AA04251290

The global ablation technology market is undergoing dynamic expansion, underpinned by the rising incidence of cardiovascular diseases (CVDs), solid tumors, and chronic pain conditions. Valued at US$ 6.82 billion in 2024, the market is expected to attain US$ 16.74 billion by 2034, growing at a CAGR of 9.82% over the forecast period. Technological evolution, especially in pulsed-field, cryo, and microwave ablation systems, is driving increased adoption, particularly in minimally invasive procedures. Countries like the U.S., Japan, India, and China are witnessing a significant surge in ablation procedures across therapeutic areas. For example, cardiac ablation volumes in the U.S. alone accounted for over 480,000 procedures in 2024, while tumor ablation exceeded 850,000 globally, with liver cancer ablation accounting for more than one-third of cases.

Innovations such as FDA-cleared pulsed-field ablation (PFA) systems, AI-enabled mapping platforms, and single-use probes are reshaping clinical practices. Additionally, outpatient and ambulatory surgical centers are increasingly preferred due to their cost-effectiveness and efficiency, with over 55% of ablation procedures in the U.S. now conducted outside traditional hospital settings. Simultaneously, Asia-Pacific countries are experiencing rapid expansion due to improving healthcare infrastructure, government-led initiatives, and increasing training for specialists in electrophysiology and oncology.

Noteworthy Market Developments

A series of advancements are reinforcing the momentum in the ablation technology landscape. Pulsed-field ablation, which reduces esophageal injury risks and procedural time, is rapidly gaining acceptance, already comprising 25% of U.S. cardiac ablation cases. AI-guided systems, such as Medtronic's Affera platform and Johnson & Johnson's fibrosis mapping tool (in partnership with Verily), are enhancing procedural accuracy and reducing repeat ablation rates. Outpatient ablation for liver tumors now facilitates same-day discharge in over 90% of cases, bolstering health system efficiency. Meanwhile, countries like India have witnessed a 22% year-on-year growth in prostate cryoablation, attributed to a substantial reduction in post-operative complications.

Companies are forming partnerships to develop hybrid ablation systems and modular kits optimized for ambulatory environments. Medtronic and GE Healthcare, for example, have collaborated to integrate real-time MRI guidance with ablation platforms, improving tumor margin visualization. These efforts are further supported by evolving reimbursement policies, such as Medicare's expanded coverage in the U.S., and public-private partnerships in Brazil aimed at reducing equipment costs and expanding access in underserved regions.

Core Growth Drivers

1. Rising Incidence of Target Conditions: Increasing prevalence of atrial fibrillation (AFib), which affects over 26 million people globally, and localized cancers is significantly contributing to the demand for ablation therapies.

2. Preference for Minimally Invasive Procedures: Ablation offers shorter recovery periods, less trauma, and reduced hospitalization costs, supporting widespread adoption.

3. Technological Innovations: The emergence of portable, AI-integrated systems and disposable probes enhances procedural outcomes and patient safety, especially in outpatient settings.

4. Government Support and Reimbursement Policies: Policies like the U.S. CMS's reimbursement updates and Asia-Pacific healthcare subsidies are creating favorable market environments.

Emerging Technology Trends

  • AI-Powered Navigation and Mapping: Used in more than 70% of cardiac labs in the U.S., these technologies optimize ablation precision and reduce procedure times.
  • Outpatient and ASC Optimization: The market is witnessing a trend toward compact, modular systems specifically designed for space-constrained ambulatory setups.
  • Cross-Specialty Integration: Devices that can cater to both cardiac and oncology applications are being prioritized by manufacturers to maximize utilization and ROI.
  • Remote Monitoring Integration: Products like Abbott's TriClip integrate real-time data capture, enabling follow-up care and reducing readmission rates.

Barriers to Optimization

  • High Equipment and Procedure Costs: Capital-intensive systems and high per-procedure costs are limiting penetration in low-income regions.
  • Regulatory Delays in Emerging Markets: Complex import regulations and delayed approvals are impeding product availability.
  • Workforce Gaps: Lack of trained electrophysiologists and interventional oncologists is a bottleneck in several developing countries.
  • Reimbursement Disparities: Coverage inconsistency across countries, especially in Europe and Latin America, restricts equitable access.

Market Segment Analysis

By Type:

Radiofrequency ablation leads the market, commanding 37% of total revenue in 2024. Its widespread use in oncology and pain management is attributed to high precision, cost-effectiveness, and robust clinical outcomes, such as an 89% 5-year survival rate in early-stage liver cancer.

Other types include:

  • Light/Laser
  • Electrical
  • Ultrasound
  • Microwave
  • Cryotherapy
  • Hydrothermal / Hydromechanical Ablation
  • Others

By Application:

Cardiovascular treatments dominate, contributing 43% of overall market share in 2024. The strong growth trajectory is fueled by guideline-recommended adoption of ablation as a first-line therapy for AFib, rising prevalence of arrhythmias, and favorable reimbursement policies.

Other key applications:

  • Cancer Treatment
  • Pain Management
  • Gynecological Treatment
  • Urological Treatment
  • Orthopedic Treatment
  • Cosmetic/Aesthetic Surgery
  • Ophthalmological Treatment
  • Others

By End Users:

Hospitals remain the primary end users, accounting for 66.35% of total utilization in 2024 due to their capacity to handle complex, multi-disciplinary cases, integrated diagnostic setups, and access to robotic systems and hybrid ORs.

Other end users include:

  • Surgical Centers
  • Ablation Centers
  • Ambulatory Surgical Centers (ASCs)

Geographic Insights

North America

Holding 48.3% of the global market share, North America is driven by high chronic disease burden, strong reimbursement frameworks, and rapid adoption of next-gen ablation platforms. Over 92% of regional revenue is concentrated in the U.S.

Europe

Europe represents 28% of the market, supported by aging populations and increasing outpatient procedure volumes. Germany and France are key contributors, though reimbursement inconsistencies across the continent pose challenges.

Asia Pacific

The fastest-growing region at a 13.2% CAGR, fueled by expanding CVD and cancer burdens, supportive government schemes, and emerging local manufacturers like Perfint Healthcare (India) and MicroPort (China).

Middle East & Africa

Adoption is rising, particularly in Gulf nations and South Africa, due to increasing private sector participation and initiatives to train specialists. However, cost barriers persist in low-income regions.

South America

Countries like Brazil and Argentina are increasing their investment in ablation infrastructure through PPPs and health system modernization programs, aiming to reduce dependency on imports and increase domestic access.

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • ASEAN/South-East Asia
  • Rest of Asia Pacific
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Colombia
  • Rest of South America

Leading Market Participants

  • Medtronic Plc
  • Boston Scientific Corporation
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Abbott Laboratories
  • Terumo Medical Corporation
  • CONMED Corporation
  • AtriCure, Inc.
  • Stryker Corporation
  • Accuray
  • Smith & Nephew
  • AngioDynamics, Inc.
  • Varian Medical Systems
  • Olympus Corporation
  • Other Prominent Players

Table of Content

Chapter 1. Research Framework

  • 1.1 Research Objective
  • 1.2 Product Overview
  • 1.3 Market Segmentation

Chapter 2. Research Methodology

  • 2.1 Qualitative Research
    • 2.1.1 Primary & Secondary Sources
  • 2.2 Quantitative Research
    • 2.2.1 Primary & Secondary Sources
  • 2.3 Breakdown of Primary Research Respondents, By Region
  • 2.4 Assumption for the Study
  • 2.5 Market Size Estimation
  • 2.6. Data Triangulation

Chapter 3. Executive Summary: Global Ablation Technology Market

Chapter 4. Global Ablation Technology Market Overview

  • 4.1. Industry Value Chain Analysis
    • 4.1.1. Material/Component Provider
    • 4.1.2. Manufacturers
    • 4.1.3. Software & Imaging Technology Providers
    • 4.1.4. Distributors and Channel Partners
    • 4.1.5. Healthcare Providers/ End Users
  • 4.2. Industry Outlook
    • 4.2.1. EXIM of Medical Instruments
    • 4.2.2. Integration of AI in Healthcare
    • 4.2.3. Overview of Device Regulation
    • 4.2.4. Digital Device Interactions in Healthcare
  • 4.3. PESTLE Analysis
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Bargaining Power of Suppliers
    • 4.4.2. Bargaining Power of Buyers
    • 4.4.3. Threat of Substitutes
    • 4.4.4. Threat of New Entrants
    • 4.4.5. Degree of Competition
  • 4.5. Market Dynamics and Trends
    • 4.5.1. Growth Drivers
    • 4.5.2. Restraints
    • 4.5.3. Opportunities
    • 4.5.4. Key Trends
  • 4.6. Market Growth and Outlook
    • 4.6.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2034
  • 4.7. Competition Dashboard
    • 4.7.1. Market Concentration Rate
    • 4.7.2. Company Market Share Analysis (Value %), 2024
    • 4.7.3. Competitor Mapping & Benchmarking
  • 4.8. Actionable Insights (Analyst Recommendation's)

Chapter 5. Global Ablation Technology Market Analysis, By Type

  • 5.1. Key Insights
  • 5.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 5.2.1. Light/Laser
    • 5.2.2. Radiofrequency (RF)
    • 5.2.3. Electrical
    • 5.2.4. Ultrasound
    • 5.2.5. Microwave
    • 5.2.6. Cryotherapy
    • 5.2.7. Hydrothermal / Hydromechanical Ablation Technologies
    • 5.2.8. Others

Chapter 6. Global Ablation Technology Market Analysis, By Application

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 6.2.1. Cardiovascular Disease Treatment
    • 6.2.2. Cancer Treatment
    • 6.2.3. Ophthalmological Treatment
    • 6.2.4. Pain Management
    • 6.2.5. Gynecological Treatment
    • 6.2.6. Urological Treatment
    • 6.2.7. Orthopedic Treatment
    • 6.2.8. Cosmetic/Aesthetic Surgery
    • 6.2.9. Others

Chapter 7. Global Ablation Technology Market Analysis, By End Users

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 7.2.1. Hospitals
    • 7.2.2. Surgical Centers
    • 7.2.3. Ablation Centers
    • 7.2.4. Ambulatory Surgical Centers (ASCS)

Chapter 8. Global Ablation Technology Market Analysis, By Region

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 8.2.1. North America
      • 8.2.1.1. The U.S.
      • 8.2.1.2. Canada
      • 8.2.1.3. Mexico
    • 8.2.2. Europe
      • 8.2.2.1. The UK
      • 8.2.2.2. Germany
      • 8.2.2.3. France
      • 8.2.2.4. Italy
      • 8.2.2.5. Spain
      • 8.2.2.6. Poland
      • 8.2.2.7. Russia
      • 8.2.2.8. Rest of Europe
    • 8.2.3. Asia Pacific
      • 8.2.3.1. China
      • 8.2.3.2. India
      • 8.2.3.3. Japan
      • 8.2.3.4. South Korea
      • 8.2.3.5. Australia
      • 8.2.3.6. ASEAN/ South-East Asia
      • 8.2.3.7. Rest of Asia Pacific
    • 8.2.4. Middle East & Africa
      • 8.2.4.1. UAE
      • 8.2.4.2. Saudi Arabia
      • 8.2.4.3. South Africa
      • 8.2.4.4. Rest of MEA
    • 8.2.5. South America
      • 8.2.5.1. Argentina
      • 8.2.5.2. Brazil
      • 8.2.5.3. Colombia
      • 8.2.5.4. Rest of South America

Chapter 9. North America Ablation Technology Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By End Users
    • 9.2.4. By Country

Chapter 10. Europe Ablation Technology Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By End Users
    • 10.2.4. By Country

Chapter 11. Asia Pacific Ablation Technology Market Analysis

  • 11.1. Key Insights
  • 11.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 11.2.1. By Type
    • 11.2.2. By Application
    • 11.2.3. By End Users
    • 11.2.4. By Country

Chapter 12. Middle East and Africa Ablation Technology Market Analysis

  • 12.1. Key Insights
  • 12.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 12.2.1. By Type
    • 12.2.2. By Application
    • 12.2.3. By End Users
    • 12.2.4. By Country

Chapter 13. South America Ablation Technology Market Analysis

  • 13.1. Key Insights
  • 13.2. Market Size and Forecast, 2020 - 2034 (US$ Bn)
    • 13.2.1. By Type
    • 13.2.2. By Application
    • 13.2.3. By End Users
    • 13.2.4. By Country

Chapter 14. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 14.1. Medtronic plc
  • 14.2. Boston Scientific Corporation
  • 14.3. Johnson & Johnson (Biosense Webster, Inc.)
  • 14.4. Abbott Laboratories
  • 14.5. Terumo Medical Corporation
  • 14.6. CONMED Corporation
  • 14.7. AtriCure, Inc.
  • 14.8. Stryker Corporation
  • 14.9. Accuray
  • 14.10. Smith & Nephew
  • 14.11. AngioDynamics, Inc.
  • 14.12. Varian Medical Systems
  • 14.13. Olympus Corporation
  • 14.14. Other Prominent Players

Chapter 15. Annexure

  • 15.1. List of Secondary Sources
  • 15.2. Key Country Markets- Macro Economic Outlook/Indicators